$351.02
▲ $2.26 (+0.6%)
WST
West Pharmaceutical Services
Health Care
Investor Score
63C+
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
56
Technical
77
Fundamental
64
Growth
33
Fair Value
100
News
63
Quality
62
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.